Size- and Burden-Stratified External Validation of Brain Metastasis Segmentation on 324 UCSF Imaging Studies

Clicks: 6
ID: 337619
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #64 of 65 articles by views in Neuro-Oncology Practice

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Independent institution-level validation of brain metastasis segmentation algorithms remains limited. We externally validated SPIRS-P1 and contextualized performance against prior algorithms and published inter-rater variability. Methods SPIRS-P1 was evaluated on 324 pre-treatment UCSF studies from 223 patients (3,449 reference-standard lesions). Per-case DSC, lesion-detection sensitivity, false positives, HD95, and NSD were evaluated by lesion size and burden. Native-space sensitivity and robustness analyses assessed dependence on preprocessing and lesion-matching definitions. Results Mean per-case DSC was 0.783 ± 0.155 (median 0.826), with 1.1 false positives per study. Sensitivity for micro, small, medium, and large lesions was 50%, 85%, 96%, and 99%, respectively; UCSF confidence intervals did not overlap Patel's internal results for micro and small lesions. Median study-level HD95 was 2.0 mm and NSD 0.936; among detected lesions, median HD95 was 1.0 mm and NSD 0.980. Native-space DSC was clinically similar to MNI-space DSC (median 0.848 vs 0.826). Conclusions SPIRS-P1 generalized well to independent UCSF data, with high sensitivity for lesions ≥125 mm³ and strong boundary agreement among detected lesions. Microlesion detection remained limited. Because the cohort contained only confirmed-positive scans, these findings support prospective evaluation as a contouring decision-support tool for known metastases but do not establish screening performance or deployment readiness.
Reference Key
openalex_W7224113919 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Jay Patel, Raymond Quinones Alvarado, Mauro Hanaoka, Long Tu, Thibault Marin, Jason Michael Johnson
Are you one of these authors? Claim your profile
Journal Neuro-Oncology Practice
Year 2026
DOI
10.1093/nop/npag110
URL
https://doi.org/10.1093/nop/npag110
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.